Table 2.
Lens- (ICL) and non-lens (non-ICL)-related complications, management and visual outcome
| No. | Preoperative UDVA/CDVA | Postoperative (final) UDVA/CDVA | Complication | Management |
|---|---|---|---|---|
| Lens-related complications | ||||
| 1 | 2/0 | 0.176/0 | Small vault | ICL exchange |
| 2 | 1.3/0.176 | 0.3/0 | ICL rotation | Surgical lens rotation (twice) |
| 3 | 1.82/0.176 | 0.4/0.176 | Toxic anterior segment syndrome | ICL removal |
| 4 | 2.3/0.3 | 0.0969/0 | Recurrent uveitis | Medical treatment |
| 5 | 1.3/0.3 | 0.176/0.176 | Recurrent ICL rotation | Surgical lens rotation (3 times) |
| 6 | 2/0 | 0.176/0.176 | Endophthalmitis | Intravitreal therapy and vitrectomy |
| 7 | 1.18/0.4 | 0.176/0.0969 | Postoperative open-angle glaucoma | Pharmacologic treatment |
| Non-lens-related complications | ||||
| 8 | 2.3/0.54 | 0.7/0.477 | Ocular trauma and macular hemorrhage with ICL luxation | Surgical lens reposition |
| 9 | 1.7/0.0969 | 0.54/0.397 | Myopic choroidal neovascularization | Antiangiogenic therapy |
| 10 | 1.7/.3 | 0.176/0.0969 | Previous retinal detachment | Post-scleral buckle ICL implantation |
| 11 | 2/1 | 1/1 | Retinal scar from previous myopic choroidal neovascularization | |
| 12 | 1.3/0 | 0.3/0.3 | Ocular trauma with secondary ocular hypertension and endothelial failure | DSAEK |
| 13 | 1.3/0.0969 | 0.54/0.54 | Post-ICL rhegmatogenous retinal detachment with macular involvment | Scleral buckle |
DSAEK Decemet’s stripping automated endothelial keratoplasty